2005
DOI: 10.1016/s0140-6736(05)67380-1
|View full text |Cite
|
Sign up to set email alerts
|

Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
146
3
10

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 264 publications
(165 citation statements)
references
References 38 publications
6
146
3
10
Order By: Relevance
“…Bone morphogenic protein-2 also up-regulated cardiac gene expression in mouse embryonic stem cells. 20 In this study, we investigated whether TGF-b1 induces ADSC cardiomyogenic differentiation in vitro. The TGF-b1 stimulatory effects on ADSC cardiogenic differentiation were evaluated by immunohistochemistry, flow cytometric analyses, and reverse transcription-polymerase chain reaction (RT-PCR).…”
Section: Introductionmentioning
confidence: 99%
“…Bone morphogenic protein-2 also up-regulated cardiac gene expression in mouse embryonic stem cells. 20 In this study, we investigated whether TGF-b1 induces ADSC cardiomyogenic differentiation in vitro. The TGF-b1 stimulatory effects on ADSC cardiogenic differentiation were evaluated by immunohistochemistry, flow cytometric analyses, and reverse transcription-polymerase chain reaction (RT-PCR).…”
Section: Introductionmentioning
confidence: 99%
“…15 In addition, several reports demonstrated that mESC-derived CMCs can integrate with host myocardium, generating electromechanical coupling capable of substituting the loss in myocardial contractile force; 16 more recently, similar therapeutic effects were demonstrated using mouse ESC-derived CMCs in a sheep model of heart failure. 17 While bulk cultures of ESCderived differentiated CMCs can be obtained from mouse ESCs using transfection of plasmids with tissuespecific promoters and marker selection, 16 …”
Section: Discussionmentioning
confidence: 99%
“…human and animal models, to varying degrees of success [7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] . In animal models, these cellbased therapies have demonstrated effectiveness in reducing infarct size and ventricular dilatation, and improving myocardial function [24][25][26] . Similar results have been demonstrated in human models, however clinical translation is limited 8,13,19 .…”
Section: Figurementioning
confidence: 99%